Exicure, Inc. to Present at Ladenburg Thalmann 2021 Healthcare Conference Jun 29, 2021 07:00AM
Exicure Announces the Closing of its Offering of Common Stock Dec 23, 2019 04:05PM
Exicure Inc. (XCUR) Prices 10M Share Common Offering at $2.75/Sh Dec 19, 2019 09:22AM
Exicure Announces Pricing of $27.5 Million Public Offering of Common Stock Dec 19, 2019 09:20AM
Exicure to Present at Upcoming Investor Conferences Sep 3, 2019 07:00AM


Aug 2, 2019 10:21AM Exicure Announces the Closing of its Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Jul 31, 2019 08:13AM Exicure Inc. (XCUR) Prices 27.5M Share Common Offering at $2/Sh; Announces Uplisting to Nasdaq Market
Jul 31, 2019 08:08AM Exicure Announces Uplisting to Nasdaq Capital Market and Pricing of $55 Million Public Offering of Common Stock
Sep 28, 2018 07:00AM Exicure, Inc. to Present at Upcoming Investor Conference and Participate in Oncology Roundtable
Sep 20, 2018 07:13AM Exicure, Inc. (XCUR) Reports Positive Phase 1 Results for Lead Immuno-Oncology Asset
Sep 20, 2018 07:00AM Exicure Announces Positive Phase 1 Results for its Lead Immuno-Oncology Asset
Aug 22, 2018 08:00AM Exicure, Inc. Announces Expected Closing of Approximately $22 Million Private Placement Offering
Jul 11, 2018 06:49AM Ladenburg Thalmann Starts Exicure (XCUR) at Buy